Physician profile
Frederick M Kohn
NPI 1427124981
$7,833.89
in general payments reported to CMS, 2019-2025
13 companies · $5,639 in 2025
The $5,639 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.27 · 2020: $74.34 · 2021: $10.37 · 2022: $147 · 2023: $96.24 · 2024: $1,807 · 2025: $5,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,200 · Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,200.00 |
| Food and Beverage | $341.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $7,200.00 | 2024-2025 | Bovine Collagen |
| Hologic Sales and Service, LLC | $148.09 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Organon LLC | $121.95 | 2024 | |
| Therapeuticsmd, INC. | $74.08 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $67.65 | 2023-2025 | |
| Pfizer INC. | $48.94 | 2024-2025 | |
| Avion Pharmaceuticals | $37.97 | 2020-2022 | |
| Exeltis, USA INC. | $35.65 | 2020-2022 | |
| Myovant Sciences INC. | $30.57 | 2022 | |
| Ascend Therapeutics US, LLC | $24.92 | 2023 | |
| Shield Therapeutics INC | $21.45 | 2023 | Accrufer |
| Lupin INC. | $12.25 | 2019 | |
| Aspira Women'S Health INC | $10.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Kohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.